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Healthy diet and proper nutrition are basic necessity of life and play a key role 
in preventing diseases. Nutrigenomics (NG) is an emerging approach in nutritional 
research which deals with the gene-diet interactions. The concept of nutrigenomics 
is not new and it is commonly associated with “inborn errors of metabolism”, the 
rare genetic (inherited) disorders in which the body cannot properly turn food into 
energy. These disorders are related to insufficient availability of metabolic enzymes 
or cofactors due to alteration of gene. Usually cure of these diseases lies in restricted 
diet. Presently non communicable diseases (NCDs) like cardiovascular diseases, 
obesity, diabetes and cancers are outnumbering the other health ailments among 
the different human populations of world. The main reason behind the occurrence 
of these NCDs is the abruptly changing life style and food habits after industrial 
revolution. With the advent of industrial revolution and economical concerns, 
the life style of people across the world has changed so much so that it resulted 
in approximately millions of death cases due to these NCDs. Study related to NG 
is one step forward in nutritional research involving the techniques of nutrition, 
molecular biology, genomics, bioinformatics, molecular medicine and epidemiol-
ogy together to understand the role of food as an epigenetic factor which unravel 
its role in the occurrence of these diseases. Hence, under the prevailing scenario 
of world health, it has become an urgency to boost NG research to find cure for 
dreaded diseases caused due to lack of healthy food and improper nutrition. Thus, 
such type of research findings ensures the effective benefit of genomic revolution 
for mankind near future.
Keywords: nutrigenomics, non communicable diseases, personalized nutrition, 
human health, genomic study
1. Introduction
Life, as a single-cell embryo, which is literally an envelope of the human diploid 
genome primed for replication. Almost every cell of a multicellular organism 
contains the same type of genetic material—its genome. Chromosomes, nucleic 
acid molecules that are the repository of an organism’s genetic information, are 
the largest molecules in a cell and may contain thousands of genes as well as 
considerable tracts of intergenic DNA. This genome has to be replicated with 
high fidelity millions of times during development to a fetal and adult stage and 
millions of times thereafter simply to replenish dead cells and cells lost as a result 
of exfoliation. Many cofactors and substrates are required for DNA replication 
and DNA repair. Any error during proof reading of DNA may lead to faulty 
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replication, accumulation of such errors may further trigger cell death by  apoptosis. 
Consequently, there is an accumulation of mutations at the base sequence or 
chromosomal level as a result of genotoxic insults due to endogenous and exogenous 
factors is now recognized as a fundamental underlying cause of developmental 
defects and accelerated aging as well as of an increased risk of degenerative condi-
tions such as infertility, immune dysfunction, cancer, and cardiovascular and 
 neurodegenerative diseases [1–5].
Dietary reference values (DRVs) provide us a guide for the appropriate intake 
of nutrients for prevention of diseases caused by deficiency (e.g., scurvy in the case 
of vitamin C deficiency) or excess (e.g., iron-overload disease, which may be fatal 
in excess iron in the cell system) [6]. It is important to determine these extreme 
conditions associated with nutritional disorders now-a-days and the biggest 
challenge lies in the prevention of these type of developmental and degenerative 
disease in populations which are not short of food, fortified food, or supplements 
but needs intervention through appropriate intake of micronutrients individually 
or in combination (nutriomes) to optimize cellular and organism performance on 
both a personal and a genetic subgroup level at different life stages. Optimization 
of cellular function ultimately depends on the prevention of damage to the nuclear 
and mitochondrial genome [7–9].
1.1 Nutrigenomics
Nutrigenomics, an globally emerging high-throughput science which depicts 
the effect of genetic variation in response to diet. The term “nutrigenomics” was 
first given by Peregrin [10] and after one year it was reviewed by Van Ommen 
and Stierum, [11]. In a molecular era, Wellen and Hotamisligil, [12], considered 
nutrients as “signalling molecules” which transmit and translate the dietary signals 
into the cell and within the cellular system it changes the expression of genes in 
nucleus leads to changes in protein and metabolite expression. Now the big question 
arises that what is happening within the cell system when we are having our meals 
in less or excess amount? So to get the answer of this question we have to study in 
detail of food-gene interlinking signaling mechanism which is the science behind 
nutrigenomics.
The sciences of nutrigenetic and nutrigenomic are based on three central factors 
i.e. firstly, there is a great inherited genomic diversity between the ethnic groups 
and individuals affected by nutrient bioavailability and its metabolism. Secondly, 
people may differ greatly in their food habit/nutrient availability and choices 
depending on cultural, geographical, economical, and taste perception differences. 
Thirdly, malnutrition (deficiency or excess) itself can affect gene expression and 
genome stability [13].
The field, nutrigenomics involves multiple disciplines under one umbrella to 
the study the designing of individual's diet that leads to stability of genomes by 
minimizing the DNA damage, epigenome alterations (DNA methylation), tran-
scriptomics (i.e. RNA and micro-RNA expression), proteomics (protein expression) 
and finally metabolomics i.e. controlled metabolite changes. Study of all the field 
individually and interlinking of all is very important.
Within nutrigenomics, the studies related to nutrient-gene interaction and its 
potential for both intra- and transgenerational effects is epigenetics [14, 15]. In genet-
ics, epigenetics is the processes which control the expression of certain genes by up/
down regulating without altering the DNA sequence, whereas the reversible changes 
of gene expression in epigenetics is due to DNA methylation, histone modification 
and chromatin-associated proteins which controls the expression of house-keeping 
genes and suppress the expression of parasitic DNA such as transposons. However, 
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epigenomics is the study which deals with the analytical part of complete epigenetic 
changes takes place on a genome in a cell/entire organism. Epigenetic processes 
strongly influenced the normal growth and development of an organism. The epig-
enomic changes can be inherited upto 2 to 3 generation, which is modified by diet.
In a nutshell, the study of nutrigenomics requires a collaborative effort to protect 
the human population from endangered diseases by maintaining the balance in 
genetics and the industries of public health, food science and culinary. It’s very 
easy task to make a tasty food by putting some lard or butter in it, and it’s going to 
be tasty and yummy. But the whole population have to accept the challenge that 
how to prepare good tasty healthy food without using much oil or butter or ghee 
or any kind of unhealthy food product which is not good for health. By observing 
the present trend of increasing lifestyle disease, personalised nutrition diet chart 
should be prescribed based on individuals genomic construction by the nutritionist 
and this will be the future aspect of nutrigenomics. This chapter has emphasized on 
the nutrigenomics approach based on gene-diet interaction in relevance to existing 
advance studies to understand its present and future prospect, and how to protect 
human population from such non-communicable diseases?
2. Dietary signals and nutrient sensors
Dealing with the complex human genome, nutrigenomics has the ability to 
decipher variability of genome in terms of wide range of nutrient concentration and 
a variety of food nutrition by identification of specific dietary signal, signal sensing 
or perceiving receptors. Ruden et al., [16] did an nutrigenomics research, an experi-
ment with Drosophila which is model organism and depicted that each and every 
nutrient have numerous targets sites with various affinities and specificities. It was 
found that, drosophila has adipose-like tissues and a lipid transport system, which 
has a similarity with humans in respect to obesity and associated diseases than any 
other model organisms. In addition, Müller and Kersten [17] recognized specialized 
cellular-sensing mechanisms and considered nutrients and dietary metabolitesas 
signaling elements. The molecular structure of the nutrients are naturally designed 
in such a way that it carries the information that how to activate a specific signaling 
pathways to hit the target site. Minor changes in structure (e.g., saturated vs unsatu-
rated fatty acids or cholesterol vs plant sterols) can have a profound influence on 
which sensor pathways are activated. Its a great challenge for the scientist to identify 
the molecular pathways and the up/downstream regulation by each nutrients. Study 
of nutrigenomics can allow the identification of molecular pathways by genome-
wide characterization of nutritional target genes. This type of information can help 
the researchers to understand the plan of action of individual nutrient and how it is 
linked with diet which has an important role in good health and diseases. Ultimately, 
nutrigenomics research will lead to development of evidence-based healthful food 
and lifestyle advice and dietary interventions for contemporary humans.
For instance, Patsouris et al., [18] revealed that though the role of PPARα 
towards obesity is unclear then also there is some clue where PPARα has some 
important function in obesity-linked pathophysiology of type 2 diabetes. Recently, 
it has been demonstrated that PPARα directly regulates expression of genes 
involved in hepatic gluconeogenesis and glycerol metabolism [18, 19]. Visceral 
obesity is linked to increased free fatty acid levels [20], elevated levels of free fatty 
acids in the cytosol promote the plasma free fatty acids to binds with the PPARα, 
and these molecules may be recognized by the liver as “hunger” or “in need of glu-
cose” signals resulting in increased gluconeogenesis in a PPARα-dependent manner, 
particularly under conditions of hepatic insulin resistance.
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Mandard et al., [19], Kersten et al., [21] reported that fasted PPARα null mice 
mutant (lack of functional PPARα) suffers from a variety of metabolic defects, 
include hypothermia, hypoglycemia, hypoketonemia, and elevated plasma-free 
fatty acid levels.
3. Nutrigenomic diseases and biomarkers
Research regarding nutrigenomics is based on the principal of individuals 
nutrition-gene-disease interaction and how to protect the mankind from endan-
gered non communicable diseases (NCDs) like cardiovascular diseases, obesity, 
diabetes, respiratory diseases, metabolic syndrome and cancers globally? Such type 
of NCDs are mediated by exposure of particular food components chronically, 
these are basically busy junk food eating lifestyle diseases of cities. These kinds of 
nutritional disorder are detected by biomarkers. It may be some disturbed lipid 
profiles to check the levels of cholesterol and/or triglycerides, increased blood 
pressure, or abnormal sensitivity of insulin as indicator of NCDs, like cardiovas-
cular disease or metabolic syndrome. These biomarkers are mainly single proteins 
or metabolites or certain body functions that leads to be an detector for proteomics 
and metabolic changes in individuals body may be a causative agent's of a variety 
of chronic diseases which depends on the particular individuals genotype. The 
molecular aspects of individuals DNA damage can be diagnosed by a number of 
complementary ways are as follows: (i) damage to single bases (e.g. DNA adducts 
such as the addition of a hydroxyl radical to guanine caused by oxidative stress); 
(ii) abasic sites in the DNA sequence (measurable by use of the aldehyde-reactive 
probe); (iii) DNA strand breaks (commonly measured using the Comet assay); 
(iv) telomere shortening (measured by terminal restriction fragment length 
analysis, quantitative PCR or flow cytometry); (v) chromosome breakage or loss 
(usually measured using micronucleus cytome assays or metaphase chromosome 
analysis), and (vi) mitochondrial DNA damage (usually measured as deletions or 
base damage in the circular mitochondrial DNA sequence). These use of damaged 
DNAs as a biomarkers were recently validated at various levels based on the nutrient 
associated evidence (cross-sectional epidemiology and intervention studies) and 
disease (cross-sectional epidemiology and prospective cohort studies) as reported 
by Fenech, [8]. The micronucleus assay in cytokinesis-blocked lymphocytes is cur-
rently the best validated biomarker for nutritional genomic studies of DNA damage. 
In addition, a well validated nutrigenomics tool is transcriptomics, it includes the 
microarray assay to analyze the mRNA copies for all actively transcribed genes. The 
advantage of this technique is within same time it can analyze the expression level 
of transcripts, thousands of genes in a single assay. In peripheral blood cells, studies 
of gene-expression patterns have been shown to be specific for diseased states. 
Whereas, Martin et al., [22] noted that disease-specific gene-expression patterns 
in blood cells have been identified for breast tumors and leukemia was revealed by 
Valk et al., [23], and those patterns now used as biomarkers for the detection of 
diseases.
4. Gene-diet-disease interaction
SNPs (Single nucleotide polymorphism) or SNVs (single nucleotide variants) 
are most widely acceptable markers now a days, responsible for genetic variation. 
Genotypic variations can be detected by SNPs or SNVs, and we can prescribe proper 
diet plan to avoid non communicable diseases (NCDs) like cardiovascular diseases, 
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obesity, diabetes and cancers. In this context, Ramos-Lopez et al., [24] revealed 
the sweet taste receptor (TAS1R2) related to taste perception and Ramos-Lopez 
et al., [25] depicted cluster of differentiation 36 (CD36), were associated with 
dyslipidemia in the peoples of Mexico, consume high amounts of carbohydrates 
and fats respectively. In addition, common variants of genes which regulate homo-
cysteine metabolism, like methylene tetra hydrofolate reductase (MTHFR) and 
methionine synthase (MTR), are linked with the increased risk for breast cancer 
among individuals who intakes lower amount of folate, vitamin B6, and vitamin 
B12 [26]. The status of Vitamin D show polymorphism among the population and 
have the ability to modulate various metabolism in the organism [27]. Interestingly, 
the SNPs of the vitamin D receptor (VDR) gene, affect the availability of vitamin 
D [28, 29], and results osteoporosis in postmenopausal women with low calcium 
intakes [30]. Moreover, SNPs in genes encoding lipid proteins such as apolipo-
protein C3 (APOC3) and apolipoprotein A1 (APOA1) conferred a higher risk of 
metabolic syndrome in subjects with a Western dietary pattern [31, 32]. Likewise, 
an increased risk of hypertension and CVD was observed with moderate and heavy 
coffee drinkers which was associated a genetic variation in the cytochrome P450 
family 1 subfamily A member 2 (CYP1A2) gene [33, 34]. Additionally, studies using 
genetic risk scores (GRS) have been examined the cumulative effect of SNPs on diet 
interactions and susceptibility of diseases. Macronutrient is having the ability to 
modify the obesity GRS with greater values of adiposity [35]. Furthermore, obesity 
GRS interacted with the intake of sugar-sweetened beverages [36], and fried food 
consumption [37] in relation to BMI and obesity in several cohort studies.
4.1 Nutrigenomics and obesity
Obesity is a chronic low-grade nutrition related inflammatory disorder and 
the important factor which is associated with a group of metabolic abnormali-
ties/comorbidities commonly includes insulin resistance and hyperinsulinemia, 
hypertension, impaired glucose tolerance, noninsulin-dependent diabetes mellitus 
cardiovascular disease (CVD), type 2 diabetes, and a number of cancers [38, 39]. 
For the progression of obesity and the associated comorbidities are resultant of 
abnormal lifestyle leading habits, so here is the perfect place where nutrigenetics 
and nutrigenomics contribute their work to minimize obesity. Now the question 
which can be raised that is; whether all the individuals or populations are affected 
with obesity if obesogenic environment is provided; the answer is no, it is based 
on genetic variability and interaction with environmental factors according to 
Nakamura et al., [40], Nettleton et al., [41], Reddon et al., [42]. With reference to 
this the obesogenic environment comprises dietary nutrients, age, gender, ethnicity, 
duration of sleep, amount of physical activity, sedentary behavior, stress, smoking, 
alcohol consumption, use of medication, and depression. So it is an conclusive evi-
dence that environmental factors is the primary cause for obesity vis gene-nutrient-
disease interaction. If an individual having a good dietary habit with specific timing 
throughout the day along with physical exercise of at least 30 min daily, then he/
she can avoid such kind of metabolic disorder and its comorbidities. Nutrigenomics 
explain us the complex interactions of genome and its regulation differences among 
the obese phenotype that vary both within and across populations [43–46].
However, Hill et al. [47] given a concept positive energy balance which include 
increased intake of energy, decreased energy output and results deposition of 
energy. In this concept energy is represented as calories, if the intake of energy from 
diet is greater than the output then it cause (i) resting metabolic rate, (ii) absorp-
tion and metabolism of dietary nutrients, (iii) heat production or thermogenesis, 
and (iv) physical activity, a state of positive energy balance results to promote 
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deposition of triacylglycerol within adipose tissue. Likely, in vice-versa condition, 
a state of negative energy balance results to promote lipolysis of triacylglycerol and 
mobilization of fatty acids from adipose tissue.
In addition, Stockard [48] described a fact that environment has an immense 
impact in obesity. 100 years ago he stated that the embryo and fetus develops in 
mother's womb can show a dramatic variation in the phenotype without changing 
the genomic constitution of the offspring while providing a moderate environmen-
tal constraint during specific periods of time in the development of the embryo. 
Along with this findings a new concept is explains the science working behind this 
i.e. epigenetic changes associated with obesity. Goldberg et al., [49] demonstrate the 
prenatal and early postnatal periods have a critical role in the developmental induc-
tion of obesity. Here, the epigenetics performed the lead role, during early nutri-
tional environment of the fetus can increase the susceptibility to develop obesity 
in later life. Epigenetics can induce a heritable changes in gene expression without 
altering the gene sequences, it is basically the integral regulating and determining 
factor of when and where specific genes are expressed. The detail methylation 
pattern of epigenetics was depicted by Bird, [50], he noted that methylation at the 
5´position of cytosine in DNA within a CpG (cytosine and guanine nucleotides 
linked by phosphate) dinucleotide is very common in mammalian genomes and 
leave a stable epigenetic mark which is transmitted through DNA replication and 
cell division. This de novo methylation is catalysed by DNA methyltransferases 
(Dnmts) 3a and 3b, and maintained through mitosis by gene-specific methylation 
of hemimethylated DNA by Dnmt1 [51].
Furthermore, different experiments done by various scientist describes versatile 
experiences related to obesity. Some evidential facts revealed by nutrigenomic 
scientists that if a new born with lower birth weight means the baby have reduced 
fat mass. Infants with lower birth weight who undergo early catch-up growth which 
is characterized by greater accumulation of fat relative to lean body mass have an 
increased risk of becoming obese in later life compared with those born at higher 
birth weights [52–54]. Similarly, in another experiment Singhal et al., [55], Singhal, 
[56] reported that infants born with lower birth weight having an catch-up growth 
were fed formula milk show increased risk of cardio-vascular disease in later life. A 
number of studies revealed that there is a greater chance of incidence of obesity in 
adults who were fed formula milk as compared to breast fed during infancy [57, 58], 
but exception are also there who were not fitted into this condition [59].
4.2 Nutrigenomics and cardiovascular disease (CVD)
Cardiovascular disease (CVD), basically a heart disease affecting the heart and 
blood vessels includes arteries, capillaries, and veins. The CAD disease includes 
atherosclerotic, coronary and ischemic heart diseases, individuals carrying such 
diseases having plaques throughout the inner walls of arteries and leads to heart 
attacks. While age, gender and genomic constitution are an immutable risk factors 
for the occurrence of CVD, modifiable risk factors play a major role in the causation 
and progression of the disease. Some of the extra risk factors which is very common 
now a days due to busy and stressful life schedule like hypertension, hyperlipidemia, 
obesity, diabetes, atherosclerosis, thrombosis and smoking is a causative agent of 
CVD. Analyzing the complexity of the etiology of CVD outlined here Juma et al., 
[60] narrate some dietary recommendation for CVD prevention based on individuals 
genetic constitutions. In nutrigenomics diet is considered as environmental factors 
and which has a direct relationship with the development of chronic diseases, the 
CVD is not aloof of that. It's a well established fact proved by scientists that the per-
sonalized diet composition has a strong risk factor for development of CVD [61–64].
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Obesity, itself is a curse in human population and is a leading risk factor to 
develop cardiovascular disease, diabetes mellitus and a number of cancers which 
is already discussed. In this context, to maintain the energy balance several poly-
morphic genes are involved to control the development of CVD in certain “favor-
able” or “unfavorable” condition [65]. Moreover, Lusis, [61] describes the role of 
atherosclerosis in the pathogenesis of CVD, it constitutes the key element and can 
be regarded as a complex combination of lipid transport and metabolism disorder 
with chronic inflammation. The levels of total cholesterol, LDL cholesterol, and 
triglycerides elevated permanently in the blood plasma which is causative agent 
for the development of atherosclerotic plagues, whereas increased levels of high 
density lipoprotein (HDL) i.e. cholesterol showed a protective role [65]. Genes 
responsible for encoding the apolipoproteins can be regulated by some signaling 
agents like hormones and enzymes but, it show differential sensitivity in population 
to develop cardiovascular diseases. In this context, individuals carrying the allele 
E4 of the apolipoprotein E gene show higher low-density lipoprotein-cholesterol 
(bad cholesterol) levels with increased intake of dietary fat as compared to those 
who carrying the E1, E2 andE3 alleles having equivalent amounts of dietary fat 
[66]. AG to A transition in the promoter of APOA1 gene is associated with increased 
HDL-cholesterol concentration but the results across studies are not consistent 
[67]. Whereas, Ordovas et al. [68] found that the allele A was associated with the 
decreased serum HDL levels. The genetic effect was reversed, however, in women 
who ate more polyunsaturated fatty acids (PUFA). In men, this type of fat effect 
was significant when alcohol consumption and tobacco smoking was considered in 
the analysis. Also specific polymorphism in genes encoding lipid transport proteins, 
their receptors, and lipid-processing enzymes and inflammation related proteins 
were shown to be associated with the characteristic changes in blood lipid concen-
trations [69–73].
To prevent or treat CVD an intense debate/discussion has been taking place for 
best dietary plan where the composition of macronutrients, the percentage of total 
fat along with different fatty acids presents are important [74–79]. Likewise, the 
source or origin of diet's composition is very essential, for e.g., individuals taken 
monounsaturated fatty acids from olive oils are different from monounsaturated 
fatty acids intake from meat and other foods of animal origin [79, 80]. Similarly, 
there is lots of controversy over the best origin and type (omega-6 and omega-3 
series) of polyunsaturated fatty acids (PUFA) as reported by Jakobsen et al., [79] 
and Russo, [81] for prevention or treatment of CVD. In a same platform and same 
type of case study done by Shai et al., [82] and Sacks et al., [83] for controlling body 
weight and cardiovascular related risk factors where emphasis is given on to take 
high carbohydrate, low fat diet in comparison to high fat, low carbohydrate diet. 
In 1965, Keys et al, [84] in their study stated that it was an individual's “intrinsic 
characteristics” which controls the effect of diet in plasma concentrations of choles-
terol, is an variable factor for person to person. Based on the facts, nutrition related 
counseling focused on weight reduction and normalization of lipid profiles through 
diet, exercise, and medication for the prevention of CVD.
4.3 Nutrigenomics and Diabetes mellitus
Diabetes mellitus (DM), a group of metabolic diseases, results from defects 
in insulin secretion and insulin activity or both which is characterized by hyper-
glycemia. Georgoulis et al. [85] reported that due to this metabolic disease DM, 
various organs like blood vessels, heart and kidneys are dysfunction and/or failure, 
and now a days this disease is considered a global burden [86]. The International 
Diabetes Federation’s recent estimates indicate that 8.3% of adults (382 million 
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individuals) have diabetes, and the number of individuals with this disease is 
expected to rise beyond 592 million in less than 25 years [86]. DM fall into two 
broad etiopathogenetic categories: type 1 and type 2 DM known as T1DM and 
T2DM, respectively. The epidemic global obesity noted by Prentice [87], he stated 
that virtually T2DM will be a major health issue in the world create a major drain on 
health budgets. Individual with obesity increases the risk of developing the disease 
DM by at least 10 fold as compared to normal one [88, 89]. In developing countries, 
peoples are shifted their lifestyle from traditional diets system to modernized 
fast food eating habit which include frequent consumption of red meat, refined 
carbohydrates and saturated fats is leads to obesity [90]. The insulin hormone, 
which is an important controller of glucose and fat metabolism is secreted from 
β-cells of pancreas. Irregular secretion insulin is observed in both the cases i.e. 
obesity and T2DM. Glucolipotoxicity is the results of high sugar and saturated fatty 
acid in diet on regular basis as suggested by Prentki et al. [91] and it negatively 
controls the secretion of insulin of from the β-cells, and results hyperglycemia and 
hyperlipidemia.
Flavonoids present in the diets include flavones, flavonols, flavanones, isofla-
vones, and anthocyanins. Various experimental studies suggested the protective 
role of polyphenols on glucose homeostasis mechanism, along with this some 
specific molecules like flavanols, luteolin, quercetin and others have a great impact 
on different steps of intracellular signalling pathways (insulin secretion, insulin sig-
nalling and glucose uptake, enhancing mitochondrial status, suppression of inflam-
matory cytokine production and reactive oxygen species (ROS)/reactive nitrogen). 
In addition to flavonoids, phenolic acids and tannins also have inhibiting property 
of the enzyme α-glucosidase and α-amylase which is responsible for carbohydrate 
digestion [92–97]. For instance, Song et al. [98] noted that consumption of apple or 
tea was associated inversely with T2DM risk. This is in accordance with the Health 
Professionals Follow-Up Studies also suggested that higher consumption of antho-
cyanins, particularly from pears, apples and blueberries, were inversely associated 
with T2DM [99].
Caffeic acid, chlorogenic acid (present in coffee) and ferulic acid (esterified to 
hemicelluloses in cereals) are the most common phenolic acids [96]. An inverse 
result with caffeinated, decaffeinated coffee and caffeine intake with T2DM in a 
dose-response manner (1–6 cups/day), compared with no or rare coffee consump-
tion was observed in different epidemiological studies, which support the hypoth-
esis i.e. habitual coffee consumption is associated with a substantially lower risk of 
T2DM [100, 101].
Resveratrol (trans-3,5,4′-trihydroxystilbene) is a natural phenol act as an 
phytoalexins, found in the skin of grapes, blueberries, mulberries, raspberries, 
peanutsand red wine, helps in reducing the complications of diabetes in many 
organs and tissues including liver and pancreatic β-cells and in different diabetic 
animal models [102]. It also improve the glucose homeostasis and give protection to 
pancreatic β-cells. It has an important role in insulin secretion and amelioration of 
metabolic disorders [103].
Whereas, Afzal et al., [104] depicted that lower vitamin D levels represent a risk 
factor for incident of T2DM in humans. However, the levels of hypovitamin D along 
with increased levels of parathyroid hormone (PTH) is an independent predictor of 
β-cell dysfunction, insulin receptor and glycemia [105]. Patients with T2DM with 
established hypovitaminosis improve glycaemia and insulin secretion by Vitamin 
D replenishment, not only through a direct action on pancreatic β-cell function but 
also via regulation of plasma calcium levels, which regulate insulin synthesis and 
secretion [106, 107].
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4.4 Nutrigenomics and cancer
Cancer is a multiple stages process in which gene expression, and protein and 
metabolite function begin to run aberrantly [108]. In today's genomic era, the cellular 
events which intercede the activation of carcinogenesis upon modulation by dietary 
factors, has led to flow of significant information which helped in understanding of 
this disease [109]. Cancer susceptibility may increase due to inherited mutations in 
genes. Gene diet interaction may increase the risk of developing cancer. Endogenous 
reactions, such as oxidations or from exogenous agents, sunlight exposure (skin 
cancer), such as tobacco smoke (lung cancer), aflatoxin (liver cancer), and relatively 
high doses of ionizing radiations (many types of cancers) [110] induces cancer.
It is mandatory to have communication between nutrition, metabolism, and 
gene expression for upholding body homeostasis. Human genome and nutrition 
jointly interacts to do the same. Individual’s health condition and susceptibility to 
disease may get affected due to this [111]. Nutrient regulates transcription factors at 
the molecular level which then modifies the gene expression (up or down), conse-
quently to adjust the metabolic responses [112].
Diet is a blend of protective, carcinogenic, and mutagenic agents all together and 
are metabolized by the enzymes of biotransformation process. Risk of developing 
cancer can be modified through genetic polymorphisms that change protein expres-
sion or the function of these enzymes. Foods ingested by humans are proposed 
to contain more than 25,000 [113]. Role of different bioactive food ingredients in 
cancer pathogenesis has been studied and found that, among these, more than 500 
types of bioactive food ingredients is proved to be possible predisposing agents.
For carcinogens, diet is considered as a source (intrinsic or cooking-generated) 
present in certain foods or constituents acting in a protective manner (vitamins, 
antioxidants, detoxifying enzyme-activating substances, etc.) [114]. Carcinogen 
metabolism affecting polymorphisms may modify probability of contact between 
carcinogens and target cells, thus acting at the stage of cancer initiation [65].
In hormone dependent tumors such as breast, prostate, ovarian and endome-
trial cancers, influences of polymorphisms of gene encoding factors involved in 
hormonal regulation are most strongly manifested. Polymorphisms in sex hor-
mone receptor genes comprising those encoding estrogen receptors, progesterone 
receptor, and androgen receptor have been shown to be associated with cancer 
risk modulation [65]. Hormonal regulation can be influenced on interaction with 
dietary factors. Obesity has strongly impact on hormonal status. Apparently, some 
food components, such as phytoestrogens are known to be processed by the path-
ways similar as sex hormones [115].
There are various examples of the effects of diet on cancer risk. High consump-
tion of red meat increase the risk of colorectal cancer [66]. N-Acetyl transferase 
(NAT) exists in two forms: NAT1 and NAT2, it is a phase II metabolism enzyme. 
Several polymorphisms exist in NAT1 and NAT2, some of them are capable of slow, 
intermediate, or fast acetylations. Heterocyclic Aromatic amines found in heated 
products like cooked red meat get through acetylation by NAT. On cooking of 
muscle meat at high temperature, some amino acids may react with creatinine to 
generate heterocyclic aromatic amines (HAA). Acetylation activates HAA to reac-
tive metabolites which bind DNA and cause cancers. This acetylation can only be 
performed by NAT2 fast acetylators. People who consumed relatively large quanti-
ties of red meat with NAT fast acetylator genotype had a higher risk of developing 
colon cancer in them [66].
Specific dietary irritants, such as salts and preservatives have been suggested as 
being carcinogens for gastric cancer [116]. C667T polymorphism in MTHFR gene 
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which reduces enzymatic activity is inversely associated with occurrence of colorec-
tal cancer. Less consumption of folate, vitamin B12, vitamin B6 or methionine in 
diet are associated with increased risk for cancer in CC or TT phenotype of MTHFR 
gene [117].
It has also been found that reactive oxygen species (ROS) such as superoxide 
anions, hydrogen peroxide, and hydroxyl radicals attack DNA bases, resulting in 
potential mistranscription of DNA sequence [118]. Such disruptions can interfere 
with DNA replication and thus produce mutations in oncogenes and tumor sup-
pressor genes. ROS can also result in breakage of DNA strand, resulting in muta-
tions or deletions of genetic material [119].
Dietary fibers have a protective effect against bowel cancer [120]. Growth of 
colonic tumors in both in vitro and in vivo systems gets inhibited on consumption of 
fish oil which is rich in omega-3 fatty acids [121–123].
Fruits and vegetables rich in bioactive components can prevent carcinogenesis 
by several mechanisms such as blocking metabolic activation through increasing 
detoxification. Detoxification enzymes as flavonoids, phenols, isothiocyanates, allyl 
sulfur compounds, indoles, and selenium can be modulated on consuming plant 
foods [124, 125].
Some of these bioactive components which may influence carcinogen metabo-
lism, cell signaling, cell cycle control, apoptosis, hormonal balance and angiogene-
sis are calcium, zinc, selenium, folate, vitamins C, D and E, carotenoids, flavonoids, 
indoles, allyl sulfur compounds, conjugated linoleic acid and N-3 fatty acids [126]. 
Bioactive ingredients which play protective role in the cancer development are 
lycopene from tomatoes, resveratrol from grapes and berries, numeric acid from 
cinnamons, hesperidin from citrus fruits, carotenoids from red vegetables and 
fruits, ascorbic acid, coffee acid from coffee, types of soluble fibers, polyunsatu-
rated and fatty acids from marine animals have [127]. Intake of proper diet with 
sufficient minerals and vitamins which are involved in regulatory and enzymatic 
processes reduces the risk of cancer. The deficiency of these micronutrients may 
lead to abnormalities. For example, zinc and folate is involved in DNA repair-
ing process. Further natural compounds from plant source like apigenin (celery, 
parsley), curcumin (turmeric), epigallocatechin-3-gallate (green tea), resveratrol 
(red grape, peanuts, and berries), genistein (soybean), and allyl sulfur (garlic) 
have been reported to affect the cell cycle by different mechanisms. Some of these 
changes may be associated with the processing of synthesized proteins at the post-
translational level like shifts in the phosphorylation process of the main regulatory 
factors of cell division [128]. Tumor behavior can also be changed by other food 
ingredients through accelerated cell death and enhanced apoptosis. Apoptosis occur 
through two known pathways: the intrinsic, mitochondrial-mediated pathway; and 
the extrinsic, death receptor-mediated pathway [129].
Many of the studies by American Cancer Society [130] have shown the reduced 
risk of cancer associated with consumption of foods rich in vitamin C, such as fruits 
and vegetables. On contrary, evidence indicates that vitamin C supplements do not 
reduce cancer risk. From the above finding it can be said that, activity of fruits and 
vegetables in preventing cancer is due to consumption of many vitamins and other 
phytochemicals in a combination, not due to vitamin C alone.
5. Conclusion
This chapter deals with the role of nutrigenomics for the prevention of non-
communicable diseases. The mother nature has made all humans almost genetically 
similar but, only 0.1% variation makes one individual unique from others with 
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respect to their phenotype and individual susceptibility to disease or health and also 
their differing response to nutrients. Interestingly, same diet can be a risk factor 
for some individuals whereas in others, it may prove beneficial. Besides, some diets 
may regulate genes to help in maintenance of health whereas, Some of them act as 
possible inducer of disease. Thus, based on knowledge of individual nutritional 
requirements, nutrition status and genotype; personalized nutrition & diet recom-
mendations can be made to maintain the balance between health and disease to 
offer a healthy life. Major challenge is, in a populous country like ours, where people 
are still fighting for their basic needs, personalized nutrition system approach is a 
dream. Now, even the rural India is not spared from this menace of non communi-
cable disease as it has also started embracing city culture, post era of globalization 
and urbanisation has brought significant changes in eating habits of rural India as 
well. At this moment, the most pertinent question is how to overcome this public 
health concern. The nutrigenomics approach is most effective and the only way 
out but on contrary it is not going to be so cheap to be available for masses. Also it 
is a very difficult task to handle the huge population with nutritional intervention 
as it will require adequate qualified professional along with advance lab facilities. 
For the time being as an alternative, public health awareness programme can play 
an important role in different way to protect the people from these diseases in 
broader sense. It shall basically focus on early identification of at-risk individuals 
and appropriate intervention in the form of weight reduction, changes in dietary 
habits and increased physical activity to help to prevent, or at least delay the onset 
of dietary disorders until India build itself capable in all respect to implement fully 
functional individual nutrigenomics approach.
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